vs
Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and MEDIFAST INC (MED). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $75.1M, roughly 1.1× MEDIFAST INC). On growth, HEALTHSTREAM INC posted the faster year-over-year revenue change (7.4% vs -36.9%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $-6.6M). Over the past eight quarters, HEALTHSTREAM INC's revenue compounded faster (4.7% CAGR vs -34.4%).
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
HSTM vs MED — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.7M | $75.1M |
| Net Profit | — | — |
| Gross Margin | — | 69.4% |
| Operating Margin | 3.0% | -10.4% |
| Net Margin | — | — |
| Revenue YoY | 7.4% | -36.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.09 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.7M | $75.1M | ||
| Q3 25 | $76.5M | $89.4M | ||
| Q2 25 | $74.4M | $105.6M | ||
| Q1 25 | $73.5M | $115.7M | ||
| Q4 24 | $74.2M | $119.0M | ||
| Q3 24 | $73.1M | $140.2M | ||
| Q2 24 | $71.6M | $168.6M | ||
| Q1 24 | $72.8M | $174.7M |
| Q4 25 | — | — | ||
| Q3 25 | $6.1M | $-2.3M | ||
| Q2 25 | $5.4M | $2.5M | ||
| Q1 25 | $4.3M | $-772.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $5.7M | $1.1M | ||
| Q2 24 | $4.2M | $-8.2M | ||
| Q1 24 | $5.2M | $8.3M |
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 72.8% |
| Q4 25 | 3.0% | -10.4% | ||
| Q3 25 | 9.9% | -4.6% | ||
| Q2 25 | 7.9% | -1.0% | ||
| Q1 25 | 6.0% | -1.1% | ||
| Q4 24 | 6.3% | 0.6% | ||
| Q3 24 | 8.9% | 1.5% | ||
| Q2 24 | 6.2% | -4.7% | ||
| Q1 24 | 7.8% | 4.5% |
| Q4 25 | — | — | ||
| Q3 25 | 8.0% | -2.5% | ||
| Q2 25 | 7.2% | 2.3% | ||
| Q1 25 | 5.9% | -0.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.8% | 0.8% | ||
| Q2 24 | 5.8% | -4.8% | ||
| Q1 24 | 7.2% | 4.8% |
| Q4 25 | $0.09 | $-1.64 | ||
| Q3 25 | $0.20 | $-0.21 | ||
| Q2 25 | $0.18 | $0.22 | ||
| Q1 25 | $0.14 | $-0.07 | ||
| Q4 24 | $0.16 | $0.08 | ||
| Q3 24 | $0.19 | $0.10 | ||
| Q2 24 | $0.14 | $-0.75 | ||
| Q1 24 | $0.17 | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $354.0M | $198.9M |
| Total Assets | $520.4M | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.2M | $167.3M | ||
| Q3 25 | $53.5M | $173.5M | ||
| Q2 25 | $52.1M | $162.7M | ||
| Q1 25 | $77.3M | $164.6M | ||
| Q4 24 | $59.5M | $162.3M | ||
| Q3 24 | $57.5M | $170.0M | ||
| Q2 24 | $46.1M | $163.5M | ||
| Q1 24 | $52.4M | $156.4M |
| Q4 25 | $354.0M | $198.9M | ||
| Q3 25 | $349.2M | $214.7M | ||
| Q2 25 | $350.6M | $216.0M | ||
| Q1 25 | $362.8M | $211.0M | ||
| Q4 24 | $359.4M | $210.1M | ||
| Q3 24 | $355.5M | $207.3M | ||
| Q2 24 | $349.2M | $205.3M | ||
| Q1 24 | $344.9M | $211.0M |
| Q4 25 | $520.4M | $248.0M | ||
| Q3 25 | $499.9M | $268.2M | ||
| Q2 25 | $500.1M | $269.3M | ||
| Q1 25 | $524.0M | $280.0M | ||
| Q4 24 | $510.8M | $284.2M | ||
| Q3 24 | $502.8M | $291.2M | ||
| Q2 24 | $499.6M | $293.5M | ||
| Q1 24 | $511.6M | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.2M | $-5.3M |
| Free Cash FlowOCF − Capex | $13.0M | $-6.6M |
| FCF MarginFCF / Revenue | 16.3% | -8.8% |
| Capex IntensityCapex / Revenue | 0.3% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | $-5.3M | ||
| Q3 25 | $18.0M | $12.1M | ||
| Q2 25 | $5.0M | $-3.4M | ||
| Q1 25 | $27.1M | $3.4M | ||
| Q4 24 | $11.2M | $-4.9M | ||
| Q3 24 | $19.1M | $9.1M | ||
| Q2 24 | $6.5M | $13.1M | ||
| Q1 24 | $20.9M | $7.3M |
| Q4 25 | $13.0M | $-6.6M | ||
| Q3 25 | $17.9M | $10.8M | ||
| Q2 25 | $2.7M | $-4.8M | ||
| Q1 25 | $26.0M | $1.9M | ||
| Q4 24 | $11.0M | $-7.2M | ||
| Q3 24 | $18.8M | $7.7M | ||
| Q2 24 | $6.3M | $11.1M | ||
| Q1 24 | $20.2M | $5.4M |
| Q4 25 | 16.3% | -8.8% | ||
| Q3 25 | 23.4% | 12.0% | ||
| Q2 25 | 3.6% | -4.5% | ||
| Q1 25 | 35.4% | 1.6% | ||
| Q4 24 | 14.8% | -6.1% | ||
| Q3 24 | 25.8% | 5.5% | ||
| Q2 24 | 8.8% | 6.6% | ||
| Q1 24 | 27.8% | 3.1% |
| Q4 25 | 0.3% | 1.8% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 3.1% | 1.3% | ||
| Q1 25 | 1.4% | 1.3% | ||
| Q4 24 | 0.3% | 1.9% | ||
| Q3 24 | 0.4% | 1.0% | ||
| Q2 24 | 0.2% | 1.1% | ||
| Q1 24 | 1.0% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 0.93× | -1.36× | ||
| Q1 25 | 6.25× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | 8.04× | ||
| Q2 24 | 1.55× | — | ||
| Q1 24 | 4.01× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
MED
Segment breakdown not available.
